α4β2* and α7 nicotinic acetylcholine receptor binding predicts choice preference in two cost benefit decision-making tasks

Neuroscience

Volumn 230, Issue , 2013, Pages 121-131

  Mendez, I A ^a   Damborsky, J C ^b   Winzer Serhan, U H ^b   Bizon, J L ^c   Setlow, B ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Acetylcholine; Delay discounting; Impulsivity; Nicotinic receptor; Probability discounting; Rat

Indexed keywords

BUNGAROTOXIN RECEPTOR; IODINE 125; NICOTINIC RECEPTOR ALPHA4BETA2;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BRAIN FUNCTION; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION MAKING; DORSAL HIPPOCAMPUS; EXPERIMENTAL RAT; HIPPOCAMPUS; LIGAND BINDING; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PREDICTIVE VALUE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOASSAY; RAT; RECEPTOR BINDING; REWARD; TASK PERFORMANCE; TISSUE DISTRIBUTION; VENTRAL HIPPOCAMPUS;

ANALYSIS OF VARIANCE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; BRAIN MAPPING; BUNGAROTOXINS; DECISION MAKING; IODINE ISOTOPES; MALE; NICOTINIC AGONISTS; PROBABILITY; PROTEIN BINDING; PYRIDINES; RATS; RATS, LONG-EVANS; REACTION TIME; RECEPTORS, NICOTINIC; REWARD; STATISTICS AS TOPIC; TIME FACTORS;

EID: 84872333039     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.067     Document Type: Article

References (75)

1. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J Pharmacol Exp Ther 1995, 274:771-782.
2. Alkondon M., Pereira E.R., Wonnacott S., Albuquerque E.X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol 1992, 41:802-808.
3. Anderson K.G., Diller J.W. Effects of acute and repeated nicotine administration on delay discounting in Lewis and Fischer 344 rats. Behav Pharmacol 2010, 21:754-764. 10.1097/FBP.1090b1013e328340a328050.
4. Bickel W., Odum A., Madden G. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology 1999, 146:447-454.
5. Breese C.R., Marks M.J., Logel J., Adams C.E., Sullivan B., Collins A.C., Leonard S. Effect of smoking history on [3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 1997, 282:7-13.
6. Breese C.R., Lee M.J., Adams C.E., Sullivan B., Logel J., Gillen K.M., Marks M.J., Collins A.C., Leonard S. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 2000, 23:351-364.
7. Cardinal R. Neural systems implicated in delay and probabilistic reinforcement. Neural Netw 2006, 19:1277-1301.
8. Cardinal R.N., Howes N.J. Effects of lesions of the nucleus accumbens core on choice between small certain rewards and large uncertain rewards in rats. BMC Neurosci 2005, 28:37.
9. Cardinal R.N., Robbins T.W., Everitt B.J. The effects of d-amphetamine, chlordiazepoxide, a-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology 2000, 152:362-375.
10. Castner S.A., Smagin G.N., Piser T.M., Wang Y., Smith J.S., Christian E.P., Mrzljak L., Williams G.V. Immediate and sustained improvements inworking memory after selective stimulation of α7 nicotinic acetylcholine receptors. Biol Psychiatry 2010, 69:12-18.
11. Chan W.K., Wong P.T., Sheu F.S. Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory. Neuropharmacology 2007, 52:1641-1649.
12. Churchwell J.C., Morris A.M., Heurtelou N.M., Kesner R.P. Interactions between the prefrontal cortex and amygdala during delay discounting and reversal. Behav Neurosci 2009, 123:1185-1196.
13. Clark L., Robbins T.W. Decision-making deficits in drug addiction. Trends Cogn Sci 2002, 6:361-363.
14. Collins A., Marks M., Pauly J. Differential effect of chronic nicotine treatment on nicotinic receptor numbers in various brain regions of mice. J Subst Abuse 1989, 1:273-286.
15. Court J.A., Lloyd S., Thomas N., Piggott M.A., Marshall E.F., Morris C.M., Lamb H., Perry R.H., Johnson M., Perry E.K. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 1998, 87:63-78.
16. Curzon P., Anderson D.J., Nikkel A.L., Fox G.B., Gopalakrishnan M., Decker M.W., Bitner R.S. Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment. Neurosci Lett 2006, 410:15-19.
17. Dallery J., Locey M.L. Effects of acute and chronic nicotine on impulsive choice on rats. Behav Pharmacol 2005, 16:15-23.
18. Durany N., Zochling R., Boissl K., Paulus W., Ransmayr G., Tatschnerf T., Danielczyk W., Jellingerg K., Deckertb J., Riederer P. Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neurosci Lett 2000, 287:109-112.
19. Euteneuer F., Schaefer F., Stuermer R., Boucsein W., Timmermann L., Barbe M.T., Ebersbach G., Otto J., Kessler J., Kalbe E. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study. Neuropsychologia 2009, 47:2882-2890.
20. Evenden J., Ryan C. The pharmacology of impulsive behavior in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology 1996, 128:161-170.
21. Finger B.C., Deacon R.M.J., Burns P., Campbell T.G. The effects of lesions of the hippocampus or orbitofrontal cortex on an operant box based intertemporal choice task in mice. J Neurosci Psychol Econ 2011, 4:217-234.
22. Floresco S.B., Onge J.R., Ghods-Sharifi S., Winstanley C.A. Cortico-limbic-striatal circuits subserving different forms of cost-benefit decision making. Cogn Affect Behav Neurosci 2008, 8:375-389.
23. Flynn D., Mash D. Characterization of l-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. J Neurochem 1986, 47:1948-1954.
24. Foulds J., Stapleton J., Swettenham J., Bell N., McSorley K., Russell M.A. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology 1996, 127:31-38.
25. Gleichgerrcht E., Ibáñez A., Roca M., Torralva T., Manes F. Decision-making cognition in neurodegenerative diseases. Nat Rev Neurol 2010, 6:611-623.
26. Granon S., Faure P., Changeux J.-P. Executive and social behaviors under nicotinic receptor regulation. Proc Natl Acad Sci U S A 2003, 100:9596-9601.
27. Granon S., Poucet B., Thinus-Blanc C., Changeux J.P., Vidal C. Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology 1995, 119:139-144.
28. Guan Z., Zhang X., Blennow K., Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport 1999, 10:1779-1782.
29. Hasselmo M.E., Sarter M. Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 2011, 36:52-73.
30. Hoebel B.G., Avena N.M., Rada P. Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol 2007, 7:617-627.
31. Hoyle E., Genn R.F., Fernandez C., Stolerman I.P. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology 2006, 189:211-223.
32. Huang L.Z., Winzer-Serhan U.H. Effects of paraformaldehyde fixation on nicotinic acetylcholine receptor binding in adult and developing rat brain sections. J Neurosci Methods 2006, 153:312-317.
33. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology off motivation and choice. Am J Psychiatry 2005, 162:1403-1413.
34. Karlawish J.H., Casarett D.J., James B.D., Xie S.X., Kim S.Y. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology 2005, 64:1514-1519.
35. Keller J.J., Keller A.B., Bowers B.J., Wehner J.M. Performance of alpha7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task. Behav Brain Res 2005, 162:143-152.
36. Kelton M.C., Kahn H.J., Conrath C.L., Newhouse P.A. The effects of nicotine on Parkinson's disease. Brain Cogn 2000, 43:274-282.
37. Kenney J.W., Gould T.J. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 2008, 38:101-121.
38. Kolokotroni K.Z., Rodgers R.J., Harrison A.A. Acute nicotine increases both impulsive choice and behavioral disinhibition in rats. Psychopharmacology 2011, 217:455-473.
39. Le Foll B., Chefer S.I., Kimes A.S., Shumway D., Stein E.A., Mukhin A.G., Goldberg S.R. Baseline expression of alpha4beta2 nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. Biol Psychiatry 2009, 65:714-716.
40. Locey M.L., Dallery J. Nicotine and the behavioral mechanisms of intertemporal choice. Behav Processes 2011, 87:18-24.
41. Loos M., Pattij T., Janssen M.C., Counotte D.S., Schoffelmeer A.N., Smit A.B., Spijker S., van Gaalen M.M. Dopamine receptor D1/D5 gene expression in the medial prefrontal cortex predicts impulsive choice in rats. Cereb Cortex 2010, 20:1064-1070.
42. Mariano T.Y., Bannerman D.M., McHugh S.B., Preston T.J., Rudebeck P.H., Rudebeck S.R., Rawlins J.N., Walton M.E., Rushworth M.F., Baxter M.G., Campbell T.G. Impulsive choice in hippocampal but not orbitofrontal cortex-lesioned rats on a nonspatial decision-making maze task. Eur J Neurosci 2009, 30:472-484.
43. Marks M., Stitzel J., Collins A. Influence of kinetics of nicotine administration on tolerance development and receptor levels. Pharmacol Biochem Behav 1987, 27:505-512.
44. McKee S.A., Harrison E.L., O'Malley S.S., Krishnan-Sarin S., Shi J., Tetrault J.M., Picciotto M.R., Petrakis I.L., Estevez N., Balchunas E. Varenicline reduces alcohol self-administration in heavy-drinking smokers. Biol Psychiatry 2009, 66:185-190.
45. Mendez I.A., Gilbert R.J., Bizon J.L., Setlow B. Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in rats. Psychopharmacology 2012, 224:489-499.
46. Mendez I.A., Simon N.W., Hart N., Mitchell M.R., Nation J.R., Wellman P.J., Setlow B. Self-administered cocaine causes long-lasting increases in impulsive choice in a delay discounting task. Behav Neurosci 2010, 124:470-477.
47. Mitchell MR, Vokes CM, Blankenship AL, Simon NW, Setlow B (2011) Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats. Psychopharmacology. PMID: 21638222.
48. Mitchell M.R., Mendez I.A., Vokes C.M., Damborsky J.C., Winzer-Serhan U.H., Setlow B. Effects of developmental nicotine exposure in rats on decision making in adulthood. Behav Pharmacol 2012, 23:34-42.
49. Mitchell S.H. Measures of impulsivity in cigarette smokers and nonsmokers. Psychopharmacology 1999, 146:455-464.
50. Mitchell S.H. Measuring impulsivity and modeling its association with cigarette smoking. Behav Cogn Neurosci Rev 2004, 3:261-275.
51. Mukhin A.G., Kimes A.S., Chefer S.I., Matochik J.A., Contoreggi C.S., Horti A.G., Vaupel D.B., Pavlova O., Stein E.A. Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. J Nucl Med 2008, 49:1628-1635.
52. Nakamura M., Oshima A., Fujimoto Y., Maruyama N., Ishibashi T., Reeves K.R. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther 2007, 29:1040-1056.
53. Pattij T., Vanderschuren L.J. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 2008, 29:192-199.
54. Perry D.C., Xiao Y., Nguyen H.N., Musachio J.L., Dávila-García M.I., Kellar K.J. Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 2002, 82:468-481.
55. Perry J.L., Carroll M.E. The role of impulsive behavior in drug abuse. Psychopharmacology 2008, 200:1-26.
56. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.-P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391:173-177.
57. Potter A.S., Newhouse P.A., Bucci D.J. Central nicotinic cholinergic systems: a role in the cognitive dysfunction in Attention-Deficit/Hyperactivity Disorder?. Behav Brain Res 2006, 175:201-211.
58. Reynolds B., Richards J., Horn K., Karraker K. Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav Processes 2004, 64:333-344.
59. Rivalan M., Ahmed S.H., Dellu-Hagedorn F. Risk-prone individuals prefer the wrong options on a rat version of the Iowa gambling task. Biol Psychiatry 2009, 66:743-749.
60. Robbins T.W., Roberts A.C. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex 2007, 17:i151-i160.
61. Simon N.W., Gilbert R.J., Mayse J.D., Bizon J.L., Setlow B. Balancing risk and reward: a rat model of risky decision making. Neuropsychopharmacology 2009, 34:2208-2217.
62. Simon N.W., Montgomery K.S., Beas B.S., Mitchell M.R., LaSarge C.L., Mendez I.A., Bañuelos C., Vokes C.M., Taylor A.B., Haberman R.P., Bizon J.L., Setlow B. Dopaminergic modulation of risky decision-making. J Neurosci 2011, 31:17460-17470.
63. St. Onge J.R., Floresco S.B. Prefrontal cortical contribution to risk-based decision making. Cereb Cortex 2010, 20:1816-1828.
64. Stopper C.M., Floresco S.B. Contributions of the nucleus accumbens and its subregions to different aspects of risk-based decision making. Cogn Affect Behav Neurosci 2011, 11:97-112.
65. Thompson A., Molina B., Pelham W., Gnagy E. Risky driving in adolescents and young adults with childhood ADHD. J Pediatr Psychol 2007, 32:745-759.
66. Warpman U., Nordberg A. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. Neuroreport 1995, 6:2419-2423.
67. Weiler J.A., Bellebaum C., Brune M., Juckel G., Daum I. Impairment of probabilistic reward-based learning in schizophrenia. Neuropsychology 2009, 23:571-580.
68. Williams M., Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008, 33:1779-1797.
69. Winstanley C.A., Theobald D.E.H., Cardinal R.N., Robbins T.W. Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci 2004, 24:4718-4722.
70. Winstanley C.A., Theobald D.E.H., Dalley J.W., Cardinal R.N., Robbins T.W. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex 2006, 16:106-114.
71. Witte E.A., Davidson M.C., Marrocco R.T. Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance. Psychopharmacology 1997, 132:324-334.
72. Woodruff-Pak D.S., Lehr M.A., Li J.G., Liu-Chen L.Y. Young and older good learners have higher levels of brain nicotinic receptor binding. Neurobiol Aging 2008, 31:1032-1043.
73. Xie X., Arguello A.A., Reittinger A.M., Wells A.M., Fuchs R.A. Role of nicotinic acetylcholine receptors in the effects of cocaine-paired contextual stimuli on impulsive decision making in rats. Psychopharmacology 2012, 223:271-279.
74. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., Sharkey J. Nicotine improves sustained attention in mice: evidence for involvement of the alpha7 nicotine acetylcholine receptor. Neuropsychopharmacology 2004, 29:891-900.
75. * nicotinic acetylcholine receptors in necessary to prevent development of sensitization to cocaine-elicited increases in extracellular dopamine levels in the ventral striatum. Psychopharmacology 2006, 187:181-188.